![Western Blot: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C14orf166.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Western-Blot-NBP2-46591-img0024.jpg "Western Blot: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C14orf166.")
| Reactivity | HuSpecies Glossary |
| Applications | WB, IHC |
| Clone | OTI2A4 |
| Clonality | Monoclonal |
| Host | Mouse |
| Conjugate | Unconjugated |
| Concentration | 1 mg/ml |
| Immunogen | Full length human recombinant protein of human C14orf166 (NP_057123) produced in E.coli. |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Host | Mouse |
| Gene | RTRAF |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.3), 1.0% BSA and 50% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Concentration | 1 mg/ml |
| Purity | Immunogen affinity purified |
-Western-Blot-NB300-560-img0004.jpg)
-Immunohistochemistry-Frozen-NB300-560-img0009.jpg)
-Immunohistochemistry-Paraffin-NB300-560-img0010.jpg)
-Western-Blot-NBP2-01763-img0004.jpg)
-Flow-Cytometry-NBP2-01763-img0005.jpg)
-Immunohistochemistry-Paraffin-NBP2-01763-img0006.jpg)
-Western-Blot-H00002038-M01-img0005.jpg)
-ELISA-H00002038-M01-img0006.jpg)
-Immunocytochemistry-Immunofluorescence-H00002038-M01-img0003.jpg)
![Immunohistochemistry EGFR Antibody [Unconjugated]](https://images.novusbio.com/images2/EGF_R_AF231_Immunohistochemistry_20892.jpg)
![Immunocytochemistry EGFR Antibody [Unconjugated]](https://images.novusbio.com/images2/EGF_R_AF231_Immunocytochemistry__Immunofluorescence_21143.jpg)
![Western Blot EGFR Antibody [Unconjugated]](https://images.novusbio.com/images2/EGF_R_AF231_Western_Blot_19925.jpg)
Secondary Antibodies |
Isotype Controls |
Diseases for CLE7 homolog Antibody (NBP2-46591)Discover more about diseases related to CLE7 homolog Antibody (NBP2-46591).
| Pathways for CLE7 homolog Antibody (NBP2-46591)View related products by pathway.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | RTRAF |
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0023.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human tonsil tissue.")
![Western Blot: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of A549 cell lysate (35ug).](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Western-Blot-NBP2-46591-img0025.jpg "Western Blot: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of A549 cell lysate (35ug).")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human breast tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0001.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human breast tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0002.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human breast tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0003.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human colon tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0004.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human colon tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0005.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human Kidney tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0006.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human kidney tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0007.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human liver tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0008.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lung tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0009.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human lung tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0010.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human Ovary tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0011.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human ovary tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0012.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human pancreas tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0013.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human pancreas tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human thyroid tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0014.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human thyroid tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0015.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human thyroid tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0016.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human endometrium tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0017.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Adenocarcinoma of Human endometrium tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0018.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human prostate tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0019.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Carcinoma of Human prostate tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0020.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human bladder tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0021.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lymph node tissue.")
![Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize2/C14orf166B-Antibody-(2A4)-Immunohistochemistry-NBP2-46591-img0022.jpg "Immunohistochemistry: C14orf166B Antibody (2A4) [NBP2-46591] - Analysis of Human lymphoma tissue.")
-Immunohistochemistry-NB500-526-img0002.jpg)
-Immunohistochemistry-NB500-526-img0001.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
-Immunohistochemistry-Paraffin-NBP1-47659-img0012.jpg)
-Immunohistochemistry-Paraffin-NBP1-47659-img0013.jpg)
-Immunohistochemistry-Paraffin-NBP1-47659-img0014.jpg)
-Western-Blot-H00002770-M01-img0007.jpg)
-Immunohistochemistry-Paraffin-H00002770-M01-img0004.jpg)
-Sandwich-ELISA-H00002770-M01-img0005.jpg)
![Corin [Biotin]](https://images.novusbio.com/images2/DATA_Corin_DY2209_ELISA_1787.jpg)
![SDS-PAGE EGF [Unconjugated]](https://images.novusbio.com/images2/EGF_236-EG_234.jpg)
![Bioactivity EGF [Unconjugated]](https://images.novusbio.com/images2/EGF_236EG_1570.jpg)
![Bioactivity EGF [Unconjugated]](https://images.novusbio.com/images/236-eg_recombinant-human-egf-protein-cf-bioactivity-25202394053..jpg)
![Neutralization Prolactin Antibody [Unconjugated]](https://images.novusbio.com/images2/Prolactin_AF682_Block_Neutralize_8947.jpg)
![Immunohistochemistry Prolactin Antibody [Unconjugated]](https://images.novusbio.com/images2/Prolactin_AF682_Immunohistochemistry_19416.jpg)
![Western Blot Prolactin Antibody [Unconjugated]](https://images.novusbio.com/images2/Prolactin_AF682_Western_Blot_20170.jpg)
![SDS-PAGE IL-3 [Unconjugated]](https://images.novusbio.com/images2/IL-3_203-IL_345.jpg)
![Bioactivity IL-3 [Unconjugated]](https://images.novusbio.com/images2/IL-3_203-IL_347.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images2/Mouse-IgG1-Isotype-Control-(MG1)-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")